Navigation Links
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
Date:9/10/2009

SAN DIEGO and BANGALORE, India, Sept. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology. A phybrid is a peptide hybrid molecule that combines the pharmacological effects of two peptide hormones into a single molecular entity.

Under the terms of the Development and Commercialization Agreement, Amylin will provide expertise in peptide hormone development, particularly in the area of phybrid technology, as well as metabolic disease therapeutics. Biocon will utilize its expertise in recombinant microbial expression to manufacture the compound and also leverage its experience in preclinical and clinical development of diabetes products.

"This agreement fully leverages the synergistic capabilities of the two companies," said Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon, Ltd. "Amylin's knowledge of peptide therapeutics and their leadership in the diabetes market, paired with Biocon's capabilities in process development, manufacturing and clinical development, provides this global program with the potential to effectively bring a novel therapy to patients living with diabetes."

"This program could unleash the potential of cutting-edge peptide science to transform the lives of patients with diabetes," said Daniel M. Bradbury, President and Chief Executive Officer, Amylin Pharmaceuticals. "We are pleased to work with Biocon, a biologics
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals Reports Second Quarter Financial Results
2. Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009
3. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
4. Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
5. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
6. Amylin Issues Statement Regarding Open Letter From Icahn
7. Icahn Issues Open Letter to Amylin Shareholders
8. Amylin Sends Letter to Shareholders
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
11. Amylin Pharmaceuticals to Webcast First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... ... a reputable source of authentic tickets for the 2015 iHeart Radio Music Festival ... music will have an act they are excited to see at this two-day festival. ... perform: Sam Smith, Coldplay, Kenny Chesney, The Who, Jason Derulo, Demi Lovato, Duran Duran, ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... Tenn. (PRWEB) , ... July 31, 2015 , ... The ... Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight ... focused on cancer research between Methodist Healthcare, The West Clinic and The University of ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, ... Inc. has re-branded their social media profiles to better connect with the public. ... to communicate, find information, share insights and opinions. The Rally Insurance Group, Inc.’s ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to the article published July 27 on My ... was contained and extinguished by the city’s fire department before it caused major damage throughout ... time of the fire, and it was a fire alarm system that tipped off fire ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3
... , FAIRFAX, Va., July 27 A new proposal ... payments for radiation therapy treatments would cause many cancer centers to ... services to cancer patients, according to a survey conducted by ASTRO, ... New technology has allowed radiation oncologists to improve cancer ...
... Minn., July 27 Mayo Clinic researchers have found that children ... risk for learning disabilities later in life than children not delivered ... the journal Anesthesiology . , , ... , "We found that the incidence of learning ...
... , , , Psychiatric ... Doctor , , OAKLAND, Calif., July 27 ... filed a complaint against Mohamed El-Sabaawi with the California Medical ... at a number of state mental health hospitals without a ...
... , , , , ... DCTH ), a medical technology company developing a minimally invasive drug ... reported on the Company,s recent progress. In addition, the Company reported its ... Recent Highlights , , , ...
... , , ... seminar, we cover issues related to the diagnosis and treatment of ... vitro fertilization including the emotional, scientific and financial aspects. Discussions include ... endometriosis and use of donor sperm or donor eggs. , ...
... , , , ... and Anthem Blue Cross and Blue Shield have come together to ... needs of Boulderites who want access to both traditional and alternative ... herbology and ayurvedic methods or more traditional treatment regimens, the Chamber ...
Cached Medicine News:Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 2Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 3Health News:Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey 4Health News:Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 2Health News:Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 3Health News:Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 4Health News:Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 5Health News:Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 6Health News:Union of American Physicians and Dentists: Court Appointee El-Sabaawi Practicing Medicine Without a License? 2Health News:Delcath Systems Provides Update on Progress 2Health News:Delcath Systems Provides Update on Progress 3Health News:Delcath Systems Provides Update on Progress 4Health News:Delcath Systems Provides Update on Progress 5Health News:Delcath Systems Provides Update on Progress 6Health News:Delcath Systems Provides Update on Progress 7Health News:Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special 'Boulder Flair' to Chamber Members 2
(Date:7/31/2015)... -- RnRMarketResearch.com adds Syringes and Needles ... provides an overview of syringes and needles currently ... databases, secondary and primary research. Complete ... spread across 124 pages, talking about 13 companies ... figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
(Date:7/31/2015)...  Boston Children,s Hospital physicians report the first ... their anatomy before undergoing high-risk brain procedures. The ... the brain,s blood vessels) that posed special treatment ... Journal of Neurosurgery: Pediatrics , the physicians ... resins to create custom, high-fidelity models of the ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 53D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... , CORALVILLE, Iowa, Dec. 16 Vivakor, ... Development agreement with Baker Consulting out of Walnut Creek, ... of South Florida. Baker Consulting has been retained ... assisting the company with its recently reported acquisition strategy. ...
... Dec. 16 Naurex Inc., a new clinical stage company ... on its novel GFPA NMDA receptor modulators, today announced that ... lead compound GLYX-13 and has successfully dosed the first subjects ... agonist (GFPA) selective modulator of the NMDA receptor, is initially ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3